VenaFlux Solutions

Assessing Plasma Infusion in cTTP patients with the VenaFlux platform

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare blood clotting disorder. Currently, there is no method to assess the...

Shear Rate - what's it got to do with platelet adhesion?

As a thrombus (blood clot) grows in size, the blood has to be diverted over and around it. In order for blood flow to be maintained, the blo

Standardised modelling of microclots in COVID-19 patients

Researchers set out to investigate if the spike protein interfered with blood flow, comparing naïve healthy PPP samples, with and without ad

Trapped! Flow studies reveal Thrombosis target

The researchers of this study focused on how recruited platelets interact with neutrophils and whether this promotes the onset of Deep Vein

Cellix Solutions model inflammation to accelerate your COVID-19 research

In this newsletter, we continue to explore how Cellix’s VenaFlux Solutions can help researchers to study mechanisms involved in the...

Cellix Solutions model endothelial dysfunction for COVID-19 research

In the current phase of Coronavirus SARS-Cov-2 pandemic, there is mounting research evidence that COVID-19 disease has a significant...

Cellix Solutions mimic microvascular thrombosis accelerating COVID-19 research

For more than 15 years, Cellix has provided researchers with solutions for mimicking physiological conditions of human blood vessels and for

5 Fantastic Findings On Thrombosis Using Cellix Tech In 2019

With World Thrombosis Day just passed, we would like to look back over five publications, using #CellixTech, that have forwarded the world&#